Emerging Technologies for
21st Century Diagnostics
Thursday, April 19, 2012
Integration of Automated Biosensor Systems for Point-of-Use
Frances S. Ligler
The Center for Bio/Molecular Science and Engineering
Naval Research Laboratory
Nanopore Detectors: Coupling Nanopores to DNA Polymerases for DNA Analysis
University of California-Santa Cruz
Santa Cruz, Calif.
Computational Fluid Dynamical Simulations of Droplet Flow and Merger in Microfluidic Channels
San José State University
San José, Calif.
An Integrated Device for Molecular Detection of Pathogens
University of Pennsylvania
Portable microfluidic chip for detection of Escherichia coli in produce and blood.
Evaluation of a microfluidic system for performance of fully automated companion diagnostics for personalized medicine.
SESSION II: Emerging Diagnostic Technologies using Mass Spectrometry
Top Down Proteomics: The Case for Whole Protein Mass Spectrometry
Neil L. Kelleher
Mass Cytometry: A Massive Step towards More Precise, Single-Cell State Analysis
DVS Sciences, Inc.
Molecular Imaging of Tissue Sections by Mass Spectrometry: Looking Beyond the Microscope
Mass Spectrometric immunoassay for the determination of clinically relevant target protein variants.
Thermo Fisher Scientific
Rapid, Sensitive Dose Assessment for Public Health Emergencies
U.S. Dept. of Health and Human Services
Friday, April 20, 2012
SESSION III: Innovative Technologies for Pathogen Diagnostics
Informatics and Single-Molecule Detection for Rapid Triage of Patients during a Public Health Emergency
Lawrence Livermore National Laboratory
Photo-induced Polymerization Detection: A Method for Rapid, Inexpensive Influenza Virus Characterization with Surveillance Applications
Quantitative, Multiplex Pathogen Detection Using Proximity-dependent DNA Ligation
Plant Research International
Wageningen, The Netherlands
Automated Multichannel System for Broadband Detection and Identification of Pathogens.
A Rapid, Sensitive Chip-based Assay for Detection of rpoB Gene Mutations Conferring Rifampin Resistance in Mycobacterium tuberculosis.
Great Basin Corporation
Salt Lake City, Utah.
SESSION IV: New Point-of-Care Technologies for the Developing and Developed World
Understanding User Needs in Low-Resource Settings for Diagnostics Development
Roger B. Peck
In Vitro Diagnostic Platforms for the Developing World
A Test Platform for Lab Quality Nucleic Acid Testing at the Point-of-Care
Alere Technologies GmbH
Development of a point-of-care rapid and sensitive bacteremia diagnostic.
Toward low-cost affinity reagents: Yeast-scFv bioprobes specific for pathogen antigens
Seattle Biomedical Research Institute